Stability of dabigatran etexilate in manufacturer's blister pack, unit-dose packaging, and community pharmacy blister pack

Canadian Journal of Hospital Pharmacy

Volumn 68, Issue 1, 2015, Pages 16-21

  Wang, Erica H Z ^a   Bolt, Jennifer L ^b   Décarie, Diane ^c   Semchuk, William ^b   Ensom, Mary H H ^d  

^a ST PAUL S HOSPITAL   (Canada)

^b REGINA QU APPELLE HEALTH REGION   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Dabigatran; Dabigatran etexilate; Drug packaging; Drug stability; Liquid chromatography

Indexed keywords

DABIGATRAN ETEXILATE;

ARTICLE; BLISTER PACK; DRUG CAPSULE; DRUG DEGRADATION; DRUG MANUFACTURE; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHARMACY; STORAGE TEMPERATURE;

EID: 84940907442     PISSN: 00084123     EISSN: 19202903     Source Type: Journal    
DOI: 10.4212/cjhp.v68i1.1420     Document Type: Article

References (7)

1. Pradaxa product monograph. Ingelheim am Rhein (Germany): Boehringer Ingelheim International GmbH; 2013 Jan 17.
2. Pradaxa product monograph. Burlington (ON): Boehringer Ingelheim Canada Ltd; 2014 Jun 24.
3. Pradaxa product monograph. Ridgefield (CT): Boehringer Ingelheim Pharmaceuticals, Inc; 2014 April.
4. Stangier J. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet. 2008;47(5): 285-95.
5. CHMP assessment report for Pradaxa. London (UK): European Medicines Agency; 2008 [cited 2013 Mar 11]. Available from: www.ema.europa.eu/docs/en-GB/document-library/EPAR---Public-assessment-report/human/000829/WC500041062.pdf
6. Product monograph: Pradaxa dabigatran etexilate capsules. In: Health Canada drug product database. Ottawa (ON): Health Canada; [cited 2014 Jul 2]. Available from: http://webprod5.hc-sc.gc.ca/dpd-bdpp/index-eng.jsp
7. Bernardi RM, Fröehlich PE, Bergold AM. Development and validation of a stability-indicating liquid chromatography method for the determination of dabigatran etexilate in capsules. J AOAC Int. 2013;96(1):37-41.